Contineum Therapeutics, INC.(CTNM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CTNM Contineum Therapeutics, INC.

盘前交易 02-10 06:50:55 EST

15.27

+0.27

+1.80%

最高15.37	最低13.86	成交量26.36万
今开14.90	昨收15.00	日振幅10.07%
总市值5.58亿	流通市值3.67亿	总股本3,653万
成交额388.83万	换手率1.10%	流通股本2,403万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CTNM","market":"US","secType":"STK","nameCN":"Contineum Therapeutics, INC.","latestPrice":15.27,"timestamp":1770670800000,"preClose":15,"halted":0,"volume":263613,"delay":0,"changeRate":0.01799999999999997,"floatShares":24025000,"shares":36529449,"eps":-2.245934,"marketStatus":"盘前交易","change":0.27,"latestTime":"02-10 06:50:55 EST","open":14.9,"high":15.37,"low":13.86,"amount":3888279.623802,"amplitude":0.100667,"askPrice":20.62,"askSize":100,"bidPrice":9.61,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.245934,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770733800000},"marketStatusCode":1,"adr":0,"listingDate":1712289600000,"exchange":"NASDAQ","adjPreClose":15.27,"postHourTrading":{"tag":"盘后","latestPrice":15.27,"preClose":15.27,"latestTime":"19:28 EST","volume":1170,"amount":17865.6162,"timestamp":1770683333362,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8760160307520163,"impliedVol":0.7745,"impliedVolPercentile":0.281},"requestUrl":"/m/hq/s/CTNM","defaultTab":"news","newsList":[{"id":"1140088540","title":"Contineum Therapeutics Inc - Pipe-791第二阶段试验预计将于2028年6月完成 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1140088540","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140088540?lang=zh_cn&edition=full","pubTime":"2025-12-12 05:46","pubTimestamp":1765489577,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics Inc - Pipe-791第二阶段试验预计将于2028年6月完成 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTNM"],"gpt_icon":0},{"id":"1163655668","title":"Contineum Therapeutics发布二期Pipe-307 Vista试验的关键数据，旨在治疗复发-缓解型多发性硬化症（Rrms）","url":"https://stock-news.laohu8.com/highlight/detail?id=1163655668","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163655668?lang=zh_cn&edition=full","pubTime":"2025-11-21 05:06","pubTimestamp":1763672781,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics发布二期Pipe-307 Vista试验的关键数据，旨在治疗复发-缓解型多发性硬化症（Rrms）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","BK4007"],"gpt_icon":0},{"id":"1155455452","title":"Contineum Therapeutics公布PIPE-791药物第1B期正电子发射断层扫描试验积极顶线数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1155455452","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155455452?lang=zh_cn&edition=full","pubTime":"2025-09-18 20:06","pubTimestamp":1758197172,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics公布了其在研药物PIPE-791第1B期正电子发射断层扫描(PET)试验的积极顶线数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","BK4007"],"gpt_icon":0},{"id":"2518209152","title":"Contineum Therapeutics, Inc.盘中异动 大幅上涨5.61%报7.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518209152","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518209152?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:12","pubTimestamp":1741623143,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时12分，Contineum Therapeutics, Inc.股票出现波动，股价急速拉升5.61%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3682.97%、3096.68%、934.35%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Aeon Biopharma, Inc.、Scisparc Ltd.，振幅分别为88.14%、78.32%、49.87%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311001223abf33647&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311001223abf33647&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CTNM","BK4007","LENZ"],"gpt_icon":0},{"id":"2518028494","title":"Contineum Therapeutics, Inc.2024财年实现净利润-42.26百万美元，同比减少286.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518028494","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518028494?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536082,"startTime":"0","endTime":"0","summary":"3月10日，Contineum Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-42.26百万美元，同比减少286.00%；其中营业收入为0.00美元，每股基本收益为-1.63美元。从资产负债表来看，Contineum Therapeutics, Inc.总负债14.78百万美元，其中短期债务1.45百万美元，资产负债比为0.15，流动比率为0.21。机构评级：截至2025年3月10日，当前有4家机构对Contineum Therapeutics, Inc.目标价做出预测，其中目标均价为25.25美元，其中最低目标价为16.00美元，最高目标价为31.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000309a268989a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000309a268989a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CTNM"],"gpt_icon":0},{"id":"2517311453","title":"Contineum Therapeutics(CTNM.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.56美元，前值为-3.32美元，预期值为-0.44美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517311453","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517311453?lang=zh_cn&edition=full","pubTime":"2025-03-07 06:57","pubTimestamp":1741301842,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics(CTNM.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.56美元，前值为-3.32美元，预期值为-0.44美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07065748578834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CTNM","LENZ"],"gpt_icon":0},{"id":"1110836424","title":"Contineum Therapeutics 2024年第四季度GAAP每股收益$(0.56)错过$(0.46)预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1110836424","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110836424?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:18","pubTimestamp":1741295923,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics（纳斯达克代码：CTNM）报告季度每股亏损$(0.56)，比分析师普遍预期的$(0.46)低21.74％。以上内容来自Benzinga Earnings专栏，原文如下：Contineum $Therapeutics(LENZ)$ (NASDAQ:CTNM) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate of $(0.46) by 21.74 percent.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","LENZ"],"gpt_icon":0},{"id":"2517816182","title":"Contineum Therapeutics, Inc.盘中异动 股价大涨5.74%报6.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517816182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517816182?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:08","pubTimestamp":1741273709,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时08分，Contineum Therapeutics, Inc.股票出现波动，股价急速上涨5.74%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306230829989ebc42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306230829989ebc42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTNM","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2517864559","title":"Contineum Therapeutics, Inc.盘中异动 临近收盘股价大跌5.16%报6.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517864559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517864559?lang=zh_cn&edition=full","pubTime":"2025-03-05 05:01","pubTimestamp":1741122119,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日05时01分，Contineum Therapeutics, Inc.股票出现异动，股价大幅下跌5.16%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305050159abe85d00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305050159abe85d00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CTNM","BK4139","BK4007"],"gpt_icon":0},{"id":"2516634971","title":"Contineum Therapeutics, Inc.盘中异动 早盘股价大涨5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634971?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:38","pubTimestamp":1741012717,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时38分，Contineum Therapeutics, Inc.股票出现异动，股价快速上涨5.82%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Entero Therapeutics Inc.、Geovax Labs, Inc.、Alto Neuroscience, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为48.65%、42.33%、31.64%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Vincerx Pharma, Inc.，振幅分别为27.23%、19.25%、18.04%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032238389637ae33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032238389637ae33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTNM","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2513216482","title":"Contineum Therapeutics, Inc.盘中异动 股价大跌5.44%报7.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513216482","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513216482?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:31","pubTimestamp":1740162660,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时31分，Contineum Therapeutics, Inc.股票出现波动，股价大幅跳水5.44%。截至发稿，该股报7.47美元/股，成交量3.4271万股，换手率0.13%，振幅7.66%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222023100988e128b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222023100988e128b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTNM","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2512622191","title":"Contineum Therapeutics, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512622191","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512622191?lang=zh_cn&edition=full","pubTime":"2025-02-19 04:21","pubTimestamp":1739910099,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日04时21分，Contineum Therapeutics, Inc.股票出现波动，股价快速下挫5.05%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Aditxt, Inc.、Allogene Therapeutics, Inc.、Solid Biosciences Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为899.47%、214.60%、172.60%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219042140988a3433&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219042140988a3433&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","CTNM"],"gpt_icon":0},{"id":"2511961226","title":"Contineum Therapeutics, Inc.盘中异动 早盘急速上涨5.57%报8.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511961226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511961226?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:40","pubTimestamp":1739544055,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时40分，Contineum Therapeutics, Inc.股票出现波动，股价急速上涨5.57%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224055a2460349&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224055a2460349&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTNM","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2508142837","title":"Contineum Therapeutics, Inc.盘中异动 早盘急速下跌5.26%报9.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508142837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508142837?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:04","pubTimestamp":1738595089,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时04分，Contineum Therapeutics, Inc.股票出现异动，股价快速跳水5.26%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为482.54%、390.34%、255.71%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为118.62%、64.33%、50.76%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203230449961701a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203230449961701a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","CTNM"],"gpt_icon":0},{"id":"2505093452","title":"Contineum Therapeutics, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505093452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505093452?lang=zh_cn&edition=full","pubTime":"2025-01-22 01:01","pubTimestamp":1737478877,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日01时01分，Contineum Therapeutics, Inc.股票出现波动，股价快速跳水5.08%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.80%。其相关个股中，Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Genelux Corporation涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为765.77%、497.64%、184.88%，振幅较大的相关个股有Channel Therapeutics Corporation、Klotho Neurosciences Inc C/Wts 21/06/2029 、Dogwood Therapeutics, Inc.，振幅分别为96.32%、41.33%、38.48%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122010118abb36707&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122010118abb36707&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CTNM","BK4139","BK4007"],"gpt_icon":0},{"id":"2504949496","title":"Contineum Therapeutics, Inc.盘中异动 大幅下挫5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504949496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504949496?lang=zh_cn&edition=full","pubTime":"2025-01-17 03:01","pubTimestamp":1737054077,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日03时01分，Contineum Therapeutics, Inc.股票出现异动，股价大幅下挫5.94%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.65%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501170301179868c19e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501170301179868c19e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","CTNM"],"gpt_icon":0},{"id":"2503647090","title":"Contineum Therapeutics, Inc.盘中异动 快速拉升6.23%报13.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503647090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503647090?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:33","pubTimestamp":1736951630,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时33分，Contineum Therapeutics, Inc.股票出现波动，股价急速上涨6.23%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Exicure, Inc.、Allovir, Inc.、Monte Rosa Therapeutics, Inc.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.65%、57.74%、35.58%，振幅较大的相关个股有Onconetix, Inc.、Eterna Therapeutics Inc.、Klotho Neurosciences, Inc.，振幅分别为14.29%、12.79%、12.00%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223350ababf31a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223350ababf31a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTNM","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2501230166","title":"Contineum Therapeutics, Inc.盘中异动 早盘大幅上涨5.03%报15.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501230166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501230166?lang=zh_cn&edition=full","pubTime":"2025-01-06 22:32","pubTimestamp":1736173959,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日22时32分，Contineum Therapeutics, Inc.股票出现波动，股价急速上涨5.03%。截至发稿，该股报15.25美元/股，成交量2125股，换手率0.01%，振幅0.00%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223239a217966b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223239a217966b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTNM","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2491374313","title":"Contineum Therapeutics, Inc.盘中异动 早盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491374313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491374313?lang=zh_cn&edition=full","pubTime":"2024-12-13 23:42","pubTimestamp":1734104573,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日23时42分，Contineum Therapeutics, Inc.股票出现异动，股价快速跳水5.07%。Contineum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。Contineum Therapeutics, Inc.公司简介：Contineum Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发新型口服小分子疗法，用于高度未得到满足的 NI&I 适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213234253a1ec54be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213234253a1ec54be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","CTNM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.contineum-tx.com","stockEarnings":[{"period":"1week","weight":0.0619},{"period":"1month","weight":0.6402},{"period":"3month","weight":0.3932},{"period":"6month","weight":1.1971},{"period":"1year","weight":0.8157},{"period":"ytd","weight":0.336}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0002},{"period":"3month","weight":0.016},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.0176}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Contineum Therapeutics, Inc.于2009年作为Versense Pharmaceuticals, Inc. (Versense)在特拉华州注册成立。2023年11月，公司更名为Contineum Therapeutics, Inc. 该公司是一家临床阶段的生物制药公司，专注于发现和开发具有高未满足需求的NI&I适应症的新型口服小分子疗法。他们针对与特定临床损伤相关的生物学途径，他们认为这些途径一旦得到调节，将明显改变疾病的进程。","exchange":"NASDAQ","name":"Contineum Therapeutics, INC.","nameEN":"Contineum Therapeutics, INC."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Contineum Therapeutics, INC.(CTNM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Contineum Therapeutics, INC.(CTNM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Contineum Therapeutics, INC.,CTNM,Contineum Therapeutics, INC.股票,Contineum Therapeutics, INC.股票老虎,Contineum Therapeutics, INC.股票老虎国际,Contineum Therapeutics, INC.行情,Contineum Therapeutics, INC.股票行情,Contineum Therapeutics, INC.股价,Contineum Therapeutics, INC.股市,Contineum Therapeutics, INC.股票价格,Contineum Therapeutics, INC.股票交易,Contineum Therapeutics, INC.股票购买,Contineum Therapeutics, INC.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Contineum Therapeutics, INC.(CTNM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Contineum Therapeutics, INC.(CTNM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}